Next, we attempted to determine whether LRRC25 could inhibit the release of ISG15 in the extracellular space by mediating the degradation of ISG15 and then inhibit the release of IFN-γ to negatively regulate the anti-tuberculosis immunity of BV2 cells. The gene discussed is IFNG; the disease is tuberculosis.